Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Faculty of Medical Sciences
    • About
    • Study
    • Research
    • Active parent page: News
    • Events
    • Contacts
    • Divisions and Institutes

COVID-19: Online tool identifies patients at highest risk of deterioration

A new risk-stratification tool which can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19 has been developed by UCL researchers, in collaboration with the UK Coronavirus Clinical Characterisation Consortium (known as ISARIC4C).

11 January 2021

Doctor in teatre checking patient vitals on screen

Breadcrumb trail

  • Faculty of Medical Sciences

Faculty menu

  • About
  • Study
  • Research
  • Current page: News
  • Events
  • Contacts
  • Divisions and Institutes

Researchers say the online tool, made freely available to NHS doctors on Friday 8 January 2021, could support clinicians’ decision making – helping to improve patient outcomes and ultimately save lives.

The tool assesses 11 measurements* routinely collected from patients, including age, gender, and physical measurements (such as oxygen levels) along with some standard laboratory tests and calculates a percentage risk of deterioration, known as the ‘4C Deterioration Score’.

This innovation, due to be published in The Lancet Respiratory Medicine, builds on the Consortium’s previous work developing the ‘4C Mortality Score’ to predict the percentage risk of death from COVID-19 after admission to hospital. The ‘4C Mortality Score’ is already recommended for use by NHS England** to guide anti-viral treatments (Remdesivir). Doctors will now see both the ‘4C Deterioration Score’ and the ‘4C Mortality Score’ at the same time, using the same tool.

Co-senior and corresponding author, Professor Mahdad Noursadeghi, said: “Accurate risk-stratification at the point of admission to hospital will give doctors greater confidence about clinical decisions and planning ahead for the needs of individual patients.

“The addition of the new 4C Deterioration Score alongside the 4C Mortality Score will provide clinicians with an evidence-based measure to identify those who will need increased hospital support during their admission, even if they have a low risk of death.”

The tool was developed using data from 74,944 individuals with COVID-19*** admitted to 260 hospitals across England, Scotland and Wales, between February 6 and August 26, 2020.

Using a multivariable logistic regression model (where several measures are used to predict an outcome), researchers tested the 11 measures (age/gender/physical measures/lab tests) against the large patient cohort, to establish how, and to what to degree each of the measures affected the likelihood of deterioration.

Furthermore, researchers assessed how well the tool performed in nine NHS regions and found that it performed similarly well in each, suggesting that it is likely to be useful across the NHS. Importantly, the new risk score showed superior performance across the NHS, in comparison to previous risk scores. 

First author Dr Rishi Gupta (UCL Institute of Global Health) said: “The scale and wide geographical coverage of the ISARIC4C study across the country was critical to the development of this prediction tool. Our analysis provides very encouraging evidence that the 4C Deterioration tool is likely to be useful for clinicians across England, Scotland and Wales to support clinical decision-making.”

The tool can potentially be incorporated into NHS Trusts’ Electronic Health Record System – used to manage all patient care – so that risk scores are automatically generated for patients.

Researchers suggest that the tool could also be used in other countries for risk-stratification, but should first be evaluated to test its accuracy in these settings.

ISARIC4C is a UK-wide consortium of NHS doctors and scientists from universities including UCL, Imperial College London, the University of Liverpool, the University of Edinburgh, and the University of Oxford.

It is principally funded by grants from the National Institute for Health Research (NIHR) and UK Medical Research Council.

*The 11 measures (demographic, clinical, and laboratory predictors) are age; gender; acquisition of infection in hospital or community; existence of infiltrates (white spots) on lung X-Ray; impairment of consciousness level (defined by the Glasgow Coma Scale); respiratory rate (breaths per minute); oxygen saturation (measured with a finger probe); blood C-reactive protein levels; level of urea (in blood); number of lymphocytes in blood; and whether or not the patient is receiving oxygen (from a breathing aid).

** NHS England guidance: Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19

***For this modelling study adults (18 or over) who had highly suspected or confirmed COVID-19 were included.

Links

  • Profile: Professor Mahdad Noursadeghi
  • Profile: Dr Rishi Gupta's academic profile
  • UCL Institute of Global Health

Image

  • Credit: Javier Matheu via Unsplash [CC BY 2.0]

Further information

  • Source: UCL News
  • Media Contact: Henry Killworth, Tel: +44 7881 833274

Highlights in Medical Sciences

New Dean of Medical Sciences appointed
Professor Emma Morris

Announcement

New Dean of Medical Sciences appointed

Internationally recognised clinician scientist, Professor Emma Morris, will take up the role of Dean of UCL's Faculty of Medical Sciences in August 2025.

28 February 2025

Lung cancer test better predicts survival in early stages of disease
Cancer Cells Dividing

Research breakthrough

Lung cancer test better predicts survival in early stages of disease

A new test developed by UCL Cancer Institute and the Francis Crick Institute can better predict lung cancer survival at diagnosis.

09 January 2025

The King and Queen meet UCL cancer specialists at UCLH
Professor Charles Swanton (left) and Professor Karl Peggs (right) meet with The King and Queen

Royal visits

The King and Queen meet UCL cancer specialists at UCLH

King Charles and Queen Camilla met UCL clinical researchers developing new cancer treatments, along with cancer patients receiving care and their families.

01 May 2024

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in